However, the model requires further refinement, particularly in elucidating the underlying biological mechanisms of ATP6V1C2, SRPX, and NT5E to better comprehend their roles in tumor progression and patient prognosis. This evidence concerns the gene ATP6V1C2 and neoplasm.